The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.
Caitlin VanOverberghe is a communications coordinator for the Indiana University School of Medicine, where she supports the Department of Orthopaedic Surgery and the Department of Ophthalmology. Having earned degrees in journalism and telecommunications ...
As a medical student, Maya Merriweather founded Melanin is the New Medicine, LLC, with the goal of increasing diversity in the field. She was pleased to have matched with IU for residency because the OB-GYN department offered a well-rounded program, with training in all aspects of care. She knows, once her training is done and she begins practicing on her own, she’ll be prepared to handle any situation.
IU School of Medicine is one of eight academic medical centers across the country involved in nuMoM2b, or the Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be. This research cohort began in 2010 and monitored pregnant people delivering a child for the first time. The research team followed these original study participants three to seven years later, examining the impact of pregnancy complications on cardiovascular health. The team continues to follow the cohort today.
PATH4YOU aims to provide all people in Indiana with high-quality, non-coercive, patient-centered, comprehensive access to contraception. This includes all birth control options—from natural family planning to pills to long-acting reversible contraception (like intrauterine devices or arm implants).
The Curious Eye is available to download for free at the Children's Eye Foundation, making it widely available to clinicians and parents. Gavin Roberts, MD, an Assistant Professor of Ophthalmology at IU School of Medicine, served as the medical advisor for the project.
The Corson Lab in the Department of Ophthalmology at Indiana University School of Medicine has developed the first drug-like inhibitor of ferrochelatase, paving the way for a new class of potential drugs for treating neovascular eye diseases.
January is National Glaucoma Awareness Month. Indiana University School of Medicine Department of Ophthalmology specializes in glaucoma research, treatment and prevention. Get to know the faculty members leading these efforts.
Arthur Willis, MD, values the education he received at the IU School of Medicine. He graduated from Indiana University in Bloomington in 1962 and immediately enrolled at IU School of Medicine. Without the experience he gained while training at IU, Willis said he wouldn’t have been the well-rounded, quick-thinking ophthalmologist he was throughout his career.
SARS-CoV-2 can cause quick and significant bone loss—even when infections of the virus that causes COVID-19 appear to be mild.
Researchers in the Department of Orthopaedic Surgery at Indiana University School of Medicine discovered that mouse models infected with the novel coronavirus lost approximately 25% of their bone mass within two weeks of contagion. They also found mouse models with a 63% increase in osteoclasts, the cells that cause bone to break down.
Orthopaedic surgeons hoping to use a common, minimally-invasive procedure to treat gunshot wounds to the hip must be aware that such surgeries come with a very high risk of complications, according to clinical research conducted by Indiana University School of Medicine faculty.